Hua Medicine completes patient enrollment for Phase III monotherapy trial of dorzagliatin - Associated Press https://t.co/x9ECA4f2NB
— IDRO (@IDROOhio) March 1, 2019
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 10:04PM
Friday, March 1, 2019
Hua Medicine completes patient enrollment for Phase III monotherapy trial of dorzagliatin - Associated Press https://t.co/x9ECA4f2NB
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 10:04PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment